The U.S. Supreme Court on Monday declined to hear an appeal by Allergan Inc of a decision invalidating the drugmaker's patents on its blockbuster dry-eye medication Restasis, handing a final victory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback